It works by looking for circulating tumour cells, also known as CTCs, which are cancer cells that may enter the bloodstream from solid organ tumours as it grows.

TruCheck is designed to detect more than 70 solid organ cancers. 

These include cancers such as breast, bowel, lung, prostate, ovarian, pancreatic, liver, kidney and melanoma, depending on the test panel used. 

It does not detect every possible cancer type and is not designed to detect blood or lymphatic cancers such as leukaemia or lymphoma.

Trucheck is only licensed for patients over the age of 35 with NO past medical hsitory of any cancern.

It is suitable for

Patients wanting proactive cancer screening beyond standard checks  

Individuals with a family history of cancer (e.g. parents, siblings).  

People at higher risk due to age or lifestyle factors (e.g. smoking, obesity). 

In large studies, TruCheck correctly detected cancer in about 88 out of 100 people who had it (sensitivity 88%), and correctly reassured 96–99 out of 100 people who didn’t (specificity 96–99%). 

TruCheck is not suitable if you have had a known or suspected cancer diagnosis. 

You are currently undergoing cancer treatment such as chemotherapy, radiotherapy or immunotherapy.  

You are under 35 with no symptoms or significant family history, unless specifically advised by your doctor.  

You wish to replace NHS screening programmes (such as mammograms, cervical smears or bowel screening). TruCheck is designed to complement, not replace, these tests.  

Trucheck is not suitable for patients with a previous history of cancer.

 For those patients, we may recommend a full body MRI scan, targeted imaging or specialist review instead, depending on your previous diagnosis and current risk. 

A consultation helps decide the safest and most appropriate screening pathway.

A negative result makes cancer much less likely, but it cannot rule it out completely. 

We advise all patients to continue attending NHS screening programmes such as cervical smears, mammograms, and bowel screening. 

We also recommending seeking medical advice should you develop any concerning symptoms outside of the screening.

 A positive result means further tests — such as scans or biopsies — are important to confirm or rule out cancer. 

TruCheck can also suggest the part of the body where the cancer may have started. 

Should you have a positive result, we will discuss this case with our in-house oncology consultant.

Most patient have this repeated yearly.

The right interval depends on your age, risk factors, previous results, family history and wider screening plan

They are different tests. 

TruCheck looks for circulating tumour cells in the blood, while a full body MRI looks for visible structural abnormalities in the body. Some patients choose one or the other, while others choose both as part of a more comprehensive cancer screening approach. The right option depends on your risk profile, family history, budget and what level of screening you want.

No. 

TruCheck and genetic cancer testing answer different questions. 

TruCheck looks for current evidence of cancer-related cells in the bloodstream. 

Genetic cancer testing looks at inherited risk and whether you may have a higher lifetime predisposition to certain cancers. For some patients, both may be useful.